• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.04% Nasdaq Down 1.11%

    Amgen Inc. (AMGN)

    -NasdaqGS
    159.01 Down 4.57(2.79%) May 26, 4:00PM EDT
    Add to Portfolio
    Prev Close:163.58
    Open:160.84
    Bid:159.22 x 100
    Ask:159.94 x 100
    1y Target Est:180.22
    Beta:0.63
    Earnings Date:Jul 27 - Jul 31 (Est.)
    Day's Range:158.00 - 162.46
    52wk Range:114.93 - 173.60
    Volume:4,078,464
    Avg Vol (3m):3,276,020
    Market Cap:120.90B
    P/E (ttm):21.46
    EPS (ttm):7.41
    Div & Yield:3.16 (2.00%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Related Video

    Comparison

    Symbol% ChgMkt Cap
    AMGNDown 2.79%120.90B
    JNJDown 0.52%279.58B
    NVSDown 1.96%246.42B
    TEVADown 1.82%50.83B

    Key Statistics

    Forward P/E (1 yr):15.09
    P/S (ttm):6.04
    Ex-Dividend Date:12-May-15

    Analysts

    Annual EPS Est (Dec-15) :9.59
    Quarterly EPS Est (Jun-15) :2.40
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):1.47

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Amgen Inc., a biotechnology company, discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses for the treatment of illness in the areas of oncology, hematology, inflammation, bone health, nephrology, cardiovascular,... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback